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ABSTRACT 
Background and Objectives: Human Papillomavirus (HPV) infection is a major risk factor for adenocarcinoma of the 
cervix. The high-risk types of the virus such as HPV16 and HPV18, which possess the E6 and E7 oncogenes, are responsible 
for approximately 50% of all cervical cancers. A rapid, sensitive and specific test has been proposed for detection of HPV to 
improve cervical cancer screening programs. 
Objectives: The aim of this study was to develop a fast PCR-ELISA assay designated as DIAPOPS (Detection of Immobilized 
Amplified Products in a One Phase System)for detection of HPV16 and HPV18 types in SCC samples and Pap smears. The 
type specific primers and probes were designed for PCR and PCR-ELISA. The amplified products were hybridized with a 
specific biotin-labeled probe for HPV18 inner amplicons. The hybrids were detected with peroxidase conjugated avidin. 
The test was performed on the paraffin block and Pap smear samples from the cervical cancer patients, and the results of 
DIAPOPS were compared with conventional PCR assay.
Results: The 70 samples (SCC and Pap smear samples) were collected from Imam Khomeini and Mirzakoochak Khan 
Hospitals in Tehran. The PCR-based method detected six HPV16 positive, three HPV18 positive and Two HPV33 positive 
samples. DIAPOPS results were compared with the conventional PCR results and they showed an increase in sensitivity 
of the DIAPOPS test. Not only all of them were confirmed by PCR-ELISA but also three samples that conventional PCR 
showed negative for HPV18, were demonstrated positive by the PCR-ELISA method. 
Conclusion: The results of the study show that modified PCR-ELISA assay is more sensitive to detect HPV types and can 
be used for diagnostic purposes.
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INTRODUCTION
High  risk  human  papillomavirus  DNA  has  been 
shown  to  be  present  in  99.7٪  of  cervical  cancers 
worldwide  (1),  therefore,  high  risk  HPV  testing 
may have implications for the clinical management 
of  women  with  cervical  lesions  (2)  and  primary 
screening for cervical cancer.
To date, the detection of HPV genotypes has been 
done  predominantly  by  L1  general  or  consensus 
primer PCR assay (3) and using the commercially 
available liquid hybridization assay, Hybrid Capture 
2  (2).  The  general  primer  PCR  assays  enable  the 
detection  of  a  broad  spectrum  of  mucosotropic 
HPV  types.  Since  the  primers  anneal  to  a  highly 
homologous  region  of  the  HPV  types,  this  allows 
specific HPV typing. Among all of the general primer 
PCR  assays,  the  GP5+/GP6+  and  MY09/MY11 
PCR systems are most frequently used and clinically 
evaluated  (4).  Following  the  general  primer  PCR 
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assays, the HPV type determination has been done 
by nucleotide sequencing (5) or oligonucleotid probe 
hybridization (Southern dot blotting) and EIA (6) of 
the PCR products. However, all of these methods are 
very laborious.
Hybridization  with  type-specific  probes  using 
PCR-ELISA  is  the  alternative  method  that  has 
been  used  to  identify  HPV  genotypes  following 
amplification with general and consensus primers 
(7). Here we developed an easy and rapid PCR-
ELISA  (DIAPOPS)  assay  that  is  suitable  for 
clinical purposes.
MATERIALS  AND METHODS
Clinical Samples. A total of 70 cervical specimens 
were  collected  from  the  women  attending  general 
practitioner  clinics  during  routine  cytological 
screening  at  the  Department  of  pathology  of  the 
Imam Khomeini and Mirza Kochak Khan hospitals. 
Sixty  four  samples  were  paraffin-embedded  tissue 
that distinguished as a sqamus cell carcinoma (scc) 
using cytological tests. Six fresh Pap smear samples 
were collected from the cervical cancer patients and 
suspended in 200 ml of physiological serum.
Sample  preparation.  For  detection  of  HPV  in 
paraffin-embedded  specimens,  the  5-µm  sections 
were cut and deparaffinized with xylene. The Lysis 
mixture  (200  µl)  was  added  to  the  samples  and 
incubated overnight at 37˚C. Then 100µl of phenol-
chloroform-isoamilalchol (25:24:1) was added. The 
solution was thoroughly mixed and centrifuged, and 
the top phase was extracted. DNA was precipitated by 
the addition of 1ml of 95% ethanol and 50µl of 3.5 M 
sodium acetate (pH 3.5). Following the centrifugation 
at 13000 rpm, the pellet was washed twice with 70% 
ethanol, dried in the room, and re suspended in 30µl 
of deionized water. 17 samples were also extracted 
using the DNA extraction kit from bioneer Inc. (Soath 
Korea)
Positive controls. The DNA was extracted from 
the Hela cell line (Pasteur Institute, Iran) using DNA 
extraction kit from bioneer Inc. The extracted DNA 
was used as a positive control.
In order to test the cross reactivity between our system 
and other viruses, the system was checked with some 
other genome of viruses including: Adenovirus, Hepatitis 
B  virus  (HBV)  and  Herpes  simplex  virus  (HSV).
Primers and Probes. The primers were designed 
and synthesized for the sequences of the E1 genes 
of  HPV16,  HPV18,  HPV31  and  HPV33  in  the 
intermediate group as described by Kanazawa and et 
al. (8). The HPVs amplified products were accurately 
identified by their product size. In order to detect the 
DNAs of HPV 16, 18, 31 and 33, four different PCR 
reactions were performed for each of samples. The 
primers for the PCR-ELISA were designed by adding 
a 10 thymidine residues and a phosphate group to the 
5́ end of the forward primers. The designed probe was 
biotinylated at the 5’ end and annealed to the region 
between forward and reverse primers in the reverse 
strand. The sequence of the probe was checked for 
hairpin loop and dimer formation for hybridization 
with  coated  primer.  All  PCR  primers,  and  PCR-
ELISA primers and probe were supplied by Bioneer 
(South Korea). The primer and the probe sequences 
are illustrated in Table1.
PCR Amplification. The PCR was performed in 
25  µl  reaction  mixtures,  using  the Amplisense  taq 
DNA polymerase (CinnaGen, Tehran, Iran). Thermal 
cycling of amplification mixture was performed in the 
gradient PCR for a total of 35-40 cycles. The cycle 
represents denaturing for 1 minute at 94˚C, annealing 
for 1 min at 49˚C for HPV16 and 31 and 44˚C for 
HPV18 and 33, and a primer extension for 1 min at 
72˚C.
The  PCR  Products  were  detected  on  1%  (w/v) 
agarose gel electrophoresis. The amplified fragments 
were  verified  using  a  Gene  Ruler  DNA  Lithnavia 
ladder (Fermentas Inc.).
The PCR-ELISA positive samples that could not be 
detected on agarose gel were tested using a 6% (w/v) 
polyacrylamide gel electrophoresis.
PCR-ELISA (DIAPOPS). PCR-ELISA was perform-
ed  according  to  the  Nunc  protocol  with  some 
modifications.  The  5΄-monophosphatated,  ten 
thymidilated  forward  primers  were  coated  on  the 
NucleoLink strips (Nunc Denmark) that is suitable 
for covalent binding of oligonucleotides. The coating 
was performed using a fresh coating buffer (forward 
primer 100 nM, cardiaamide 10 mM, imidazole 10 
mM; pH = 7) for 24 h at 50˚C, and 100 µl for each 
well. Following the 3 times washing steps, each time 
for  5  minutes  with  washing  buffer  (Trist-HCl  100 
mM, NaCl 150 mM, tween 20 0.1%; pH = 7.5) and 
deionized water , the PCR reaction was performed in 179 PAPILLOMAvIRUS 18 IN CERvICAL CANCER
each well.
The  PCR  condition  was  at  the  same  as  PCR 
described above, except that the reaction was done 
in the coated NucleoLink stripe and in the reaction 
mixture, the forward primer (coated primer ) was 1/8 
the reverse primer, and 2.5 µl BSA 10% were used in 
the 25 µl reaction mixture.
In order to detect the HPV DNA types, the PCR 
products were treated by the denaturing buffer (NaOH 
0.2 M, tween 20 0.1%), and then were washed with 
the washing buffer (Trist-HCl 100 mM, NaCl 150 
mM, tween 20 0.1%; pH = 7.5). At the next step, the 
hybridization buffer (biotinylated probe 50 nM, SSC 
5X{from the SSC 20X containing, NaCl 175.3 gr, 
Sodium citrate 88.2 gr, adjust with water to 1 lit; pH 
= 7} tween 20 0.1%, BSA 0.5%) was added to each 
well. The wells were sealed and incubated for just 1 h 
rather than 20 h in 50˚C. Then, the wells were washed 
with buffer containing SSC 0.5X and tween 20 0.1%, 
five times and each time for 5 minutes at the room 
temperature, except the third round that was done in 
the 50˚C and for 15 minutes. The detection buffer 
(1/5000 diluted HRP-avidin, Tris-HCl 100 mM pH 
= 7.5, NaCl 150 mM, tween 20 0.1%; BSA 0.5%) 
was added to each well, and the wells were sealed 
and incubated in 50˚C for 30 minutes. After three 
times washing the wells with the washing buffer, 100 
µl of ready to use TMB mixture were added to each 
well. The  reaction  of  the  enzyme  was  blocked  by 
0.1 M H2SO4, after appearance the color in positive 
controls. The results were read on the ELISA reader.
Cut-off value of probability. In order to determine 
cut-off value of probability for DIAPOPS, 64 negative 
Fig. 1. The figure shows the results of conventional PCR. CO, negative control, lines 1 and 2: HPV16, line3: HPV33, and 
line 4:HPV18.
                    Primers Sequences (5’→3’) Tm˚C Amplified DNA size (bp)
HPV-16,F
HPV-16,R
ACCCAGTATAGCTGACAGT
CTCGTTTATAATGTCTACACA
68.3
68.3
512
HPV-31,F
HPV-31,R
ATAGCAATTTTGATTTGTC
AAACTCATTCCAAAATATG
68.7
68.7
188
HPV-18,F
HPV-18,R
ATAGCAATTTTGATTTGTC
AAACTCATTCCAAAATATG
64.3
64.3
415
HPV-33,F
HPV-33,R
ATGCACAACTTGCAGATTC
AAACTCATTCCAAAATATG
64.6
64.2
334
DIAPOPS forward primer HPV-18
P-TTTTTTTTTT- ATAGCAATTTTGATTTGTC
DIAPOPS probe
HPV-18
biotin-TGTGCAAACATTATAGGCGAGCC
Table1. primer and probe sequences. 

Fig.1.ThefigureshowstheresultsofconventionalPCR.CO,negativecontrol,lines1and2:
HPV16,line3:HPV33,andline4:HPV18.

Table1.primerandprobesequences
Primers                   
Sequences(5’ї3’) Tm°c AmplifiedDNAsize(bp)
HPVͲ16,F
HPVͲ16,R
ACCCAGTATAGCTGACAGT
CTCGTTTATAATGTCTACACA

68.3
68.3
512
HPVͲ31,F
HPVͲ31,R
  
ATAGCAATTTTGATTTGTC
AAACTCATTCCAAAATATG
68.7
68.7
188
HPVͲ18,F
HPVͲ18,R
ATAGCAATTTTGATTTGTC
AAACTCATTCCAAAATATG 
64.3
64.3
415
HPVͲ33,F
HPVͲ33,R
ATGCACAACTTGCAGATTC
AAACTCATTCCAAAATATG 
64.6
64.2
334
DIAPOPSforwardprimerHPVͲ18

PͲTTTTTTTTTTͲ
ATAGCAATTTTGATTTGTC
DIAPOPSprobe
HPVͲ18
biotinͲ
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samples were used and after the detection procedure, 
the results were read by the same ELISA-reader that 
used or clinical samples. The positive cut-off value 
for  PCR-ELISA  was  determined  according  to  the 
equation  below  for  probability  of  100%:  positive 
cut-off = X +Z (α/2). σ/√N, where the Z (α/2) is equal 3, 
Average (X) = 0. 308174, standard deviation (σ) = 0. 
174754 and N = 64, positive cut-off is as calculated 
below: Cut-off. = 0. 308174 + 3 (0. 174754/√64) = 
0.373. A test was supposed positive, if optical density 
of the sample was higher than the cut-off value (9).
RESULTS
PCR based detection of HPv types. In this study, 
70 clinical samples were tested with PCR for detection 
the HPV types 16, 18, 31 and 33. The results of the 
PCR products gel electrophoresis were shown in Fig.   
1.  Six  samples  were  detected  as  HPV16  Positive, 
three samples as HPV18 positive and two samples as 
HPV33 positive from total of 70 samples.
DIAPOPS. The PCR-ELISA assay was designed 
for HPV18 and the results of the test was compared 
with  the  conventional  PCR  method.  Following 
determination  of  positive  cut-off,  all  the  samples 
that  had  the  OD  above  the  positive  cut-off,  were 
supposed  as  infected  samples.  Sixty  four  negative 
samples were used for cut-off in DIAPOPS and then 
all samples were tested for detection of HPV18 using 
PCR-ELISA. The results showed that DIAPOPS not 
only detected all the samples which were reported 
as positive in conventional PCR, but also it detected 
three samples as a positive HPV18 that were reported 
as negative HPV18 samples in the PCR.
In order to confirm the results, the PCR products 
of DIPOPS positive samples were tested on 6% (w/v) 
polyacrylamide  gel  electrophoresis  and  the  results 
of PCR-ELISA were confirmed on the PAGE. The 
comparison of three methods is shown in Table 2.
DISCUSSION
Cervical cancer is one of the main risk factors in   
mortality  of  women  worldwide.  Evidence  shows 
strong  relation  between  cervical  cancer  and  HPV 
infection.  HPV  is  not  able  to  be  cultured  in  the 
laboratory  from  clinical  samples  and  immunologic 
assays are not adequate for detection of HPV infections 
(10). The primary detection tools have been cytology 
and histology. The sensitivity of cytological method 
that uses Pap smear samples is too low (11).
The alternative HPV testing is based on detection 
of HPV DNA in cervical specimen that is performed 
using PCR technique. Conventional PCR has higher 
sensitivity and efficiency of detection when compared 
to histological examination. The majority of studies 
using PCR have used consensus primers to amplify 
HPV  types  in  a  single  PCR  amplification.  These 
primers  target  conserved  regions  of  HPV  genome 
such as the L1 capsid gene. The MY09-MY11 primers 
target a 450-bp fragment within the HPV L1-ORF 
(10). The type specific PCR assays are based on the 
sequence  variations present in the E6 and E7 genes 
of HPV subtypes (8). 
The advantages of detecting viral DNA by PCR 
include rapidity, sensitivity, ability to detect nonviable 
virus  and  potential  elimination  of  contaminating 
microorganisms.  Traditionally,  PCR  products 
are  detected  by  agarose  gel  electrophoresis.  This 
detection  system  has  several  disadvantages.  It  is 
time consuming and difficult to standardize since the 
results are not based on figures. Gel electrophoresis 
gives a poor detection limit, is not specific and only 
subjective product quantification is possible unless 
a gel scanner is available. These problems can be 
overcome by PCR-ELISA.
Venturoli and Zerbini in 1998 used PCR-ELISA 
method for detection of HPV. They used consensus 
primer pair MY09-MY11 in PCR amplification. The 
amplified  DNA  was  labeled  with  digoxigenin  and 
A5 H7 E6 A4 H3 B1 Samples
_ _ _ + + + Agarose results
_ + + + + + Polyacrylamide result
+ + +
+ + + DIAPOPS result
--+ -++ -++ +++ +++ +++ conclusion
 Table 2. The results of conventional PCR, DIAPOPS and PAGE electrophoresis for the detection of HPV18.181 PAPILLOMAvIRUS 18 IN CERvICAL CANCER
the  hybridization  occurred  between  PCR  product 
and biotinylated probe. The plat wells coated with 
streptavidin, therefore hybrid entraps by interaction 
between  biotin  and  streptavidin.  The  detection  is 
performed by Dig antibody conjugated enzyme (7, 
12).  In  this  method,  amplification  system  and  the 
detection  system  are  separate;  therefore,  there  is 
risk of contamination. Another disadvantage of this 
method is that the detection system by DIG and anti-
Dig is expensive. In this study, DIAPOPS method 
was used and these problems can be overcome using 
the Nucleolink strips. Since there is no transfer of 
amplified  products  between  amplification  system 
and the detection system, the risk of contamination 
carry over is greatly reduced. As well as the high 
sensitivity  and  specificity  of  this  DIAPOPS,  there 
is  also  the  advantage  that  with  this  procedure  the 
PCR product is rapid, easy and objective it requires 
no  electrophoresis,  UV  light,  or  darkroom  and 
furthermore the use of toxic chemical agents such 
as ethidium bromide is avoided (9). Moreover, the 
technique allows the simultaneous handling of a large 
number of samples and can be automated.
In  this  study,  the  HPV  type16,  18,  33  and  31 
were detected by PCR in suspected cervical cancer 
samples  and  DIAPOPS  method  was  designed  for 
HPV18.  Results were compared with conventional 
PCR.  Seventy  samples  (SCC  and  Pap  smears 
samples) were collected from Imam Khomeini and 
Mirzakoochak Khan Hospitals in Tehran. Of the70 
specimens  analyzed  by  PCR,  11  were  HPV  DNA 
positive  (15.71%),  six  samples  were  detected  as 
HPV16  positive  (8.5%),  three  samples  as  HPV18 
positive (4.3%) and two samples as HPV33 positive 
(2.85%).  From a total of 70 samples for HPV18 in 
PCR-ELISA,  6  samples  were  detected  as  positive 
(8.5%);  therefore,  positive  samples  increased  from 
4.3% by gel electrophoresis to 8.5% by PCR-ELISA. 
These results are the same as other studies.   Zerbini   
and  Venturoli  reported  that  of  the  176  cytological 
specimens, 106 were HPV DNA positive (60.2%); 
of the 106 HPV DNA positive specimens, 22 were 
positive  by  agarose  gel  electrophoresis  (20.7%) 
whereas 84 (79.2%) HPV positive specimens could 
be typed by the PCR-ELISA (12).
The  results  of  the  study  show  that  PCR-ELISA 
method  modified  in  this  study  was  more  sensitive 
to HPV type  detection in comparison to PCR alone. 
This method can be used for HPV oncogenic viral 
type detection in one day for clinical purposes.
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